Moyes JAY M
SEC-identified person · CIK 1191062 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Puma Biotechnology, INC. PBYI | Director | filed 2012 - 2026 |
| Sintx Technologies, Inc. SINT | Director · Chief Fnancial Officer | filed 2014 - 2026 |
| Tiger X Medical, Inc. clik | Director | filed 2016 - 2025 |
| Sera Prognostics, INC. SERA | Chief Financial Officer | filed 2021 - 2023 |
| Sonus Pharmaceuticals INC ogxi | Director | filed 2017 - 2022 |
| Predictive Technology Group, INC. PRED | Director | filed 2019 - 2019 |
| Osiris Therapeutics, INC. OSIR | Director | filed 2006 - 2014 |
| Myriad Genetics INC MYGN | Chief Financial Officer | filed 2006 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.